Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure
NCT ID: NCT03911947
Last Updated: 2021-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
113 participants
INTERVENTIONAL
2019-05-02
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19
NCT04435353
Outcome Comparisons of Vibratory Airway Clearance Devices
NCT05873504
Determination of Normal Values of Regional Pulmonary Strain Using a New Ultrasonographic Tool in Healthy Volunteers
NCT04194346
Efficacy of Two Intermittent Subglottic Secretion
NCT03871985
A New Ultrasonographic Tool to Assess Pulmonary Strain in Patients Under One-lung Ventilation.
NCT03817918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SaO2 (oxygen status)
Measurment 4 times per day, ABA (acid-bases analyses)
Vibrolung
Device for vibroacoustic respiratory therapy
PaO2/FiO2 (respiratory index)
Measurment 4 times per day, ABA (acid-bases analyses)
Vibrolung
Device for vibroacoustic respiratory therapy
AB (actual bicarbonat level)
Measurment 4 times per day, ABA (acid-bases analyses)
Vibrolung
Device for vibroacoustic respiratory therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibrolung
Device for vibroacoustic respiratory therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* P/F less 300 torr
* ARDS by Berlin convention
Exclusion Criteria
* acute stroke
* acute coronary syndrome
* DVT
* implanted pacemaker
* rib fracture
* infection on chest
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astana Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aidos Konkayev
Chair of department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City clinical hospital №7
Almaty, , Kazakhstan
City clinical hospital №1
Astana, , Kazakhstan
National Cardiac Surgery Center
Astana, , Kazakhstan
Scientific Research Institute of Traumatology and Orthopedics
Astana, , Kazakhstan
Regional cardiology center
Shymkent, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1972
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.